No Data
Dow Falls After Record, Trump Talks Tariffs on Day One | Live Stock
Moderna Analyst Ratings
Moderna, Inc. (MRNA): An Oversold Healthcare Stock to Invest In Now
Moderna's Shares Surge Amid Promising Vaccine Developments and Strategic Partnerships
JPMorgan Adjusts Price Target on Moderna to $45 From $59, Maintains Underweight Rating
Moderna Options Spot-On: On November 25th, 105.46K Contracts Were Traded, With 667.74K Open Interest